IL1R2 and Alzheimer disease: Decreased levels of the endogenous IL-1 receptor antagonist (IL-1ra) in cerebrospinal fluid (CSF) from AD patients may indicate an imbalance between IL-1 and IL-1ra in the AD brain [21], whereas the increased levels of the soluble IL-1 receptor type II (sIL-1RII) [22] may suggest an attempt to balance the inflammation.